What are the AASLD guidelines for hepatitis C (HCV) screening?

Updated: Jul 29, 2019
  • Author: Joel Schifter, MD; Chief Editor: Eric B Staros, MD  more...
  • Print


The American Association for The Study of Liver Disease (AASLD) recommends screening in high-risk groups including intravenous illicit drug abuse, intranasal drug users who share paraphernalia, individuals who have received a blood component transfusion or organ transplant before 1992, hemophiliacs who have received blood products before 1987, unexplained elevations of aminotransferase levels (AST/ALT), patients ever on hemodialysis, children born to HCV-infected mothers, those with HIV, health care and other workers after a needle stick injury or mucosal exposure to HCV-positive blood, and current sexual partners of individuals with HCV infection. [1]

A study by Radwan et al indicated that screening for hepatitis C virus (HCV) in persons with HIV is not carried out comprehensively in the United States. The investigators reported that HCV antibody screening was performed in 77.9% of 29,071 persons with HIV. [6]

Did this answer your question?
Additional feedback? (Optional)
Thank you for your feedback!